Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

532 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group.
Fockens P, Mulder CJ, Tytgat GN, Blok P, Ferwerda J, Meuwissen SG, Tuynman HA, Dekker W, Gasthuis K, van Hees PA, et al. Fockens P, et al. Eur J Gastroenterol Hepatol. 1995 Nov;7(11):1025-30. doi: 10.1097/00042737-199511000-00003. Eur J Gastroenterol Hepatol. 1995. PMID: 8680900 Clinical Trial.
532 results